Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for JANUVIA
- SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)
- The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
- Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host Disease
- Effects of Sitagliptin in Individuals With Genetically Decreased DPP4
- Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients
- Study of Sulphonylurea Synergy With DPP4 Inhibitors
- Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy
- Drug Interaction Study Between Dorzagliatin and Sitagliptin
- Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
- Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome
- Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
- Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin
- Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes
- Treatment of Diabetes in Patients With Systolic Heart Failure
- HbA1c Variability in Type II Diabetes
- Sitagliptin in Non-Diabetic Patients Undergoing General Surgery
- Effect of Sitagliptin on Progression of Coronary Intermediate Lesion
- TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.
- A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection
- 12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin
- Effect of DPP4 Inhibition on Vasoconstriction
- A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
- Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity
- Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery
- Sitagliptin Therapy and Kinetics of Inflammatory Markers
- Treatment of Hypoglycemia Following Gastric Bypass Surgery
- Sitagliptin for Reducing Inflammation and Immune Activation
- Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)
- Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes Mellitus
- Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM
- Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery
- Sitagliptin and Endothelial Dysfunction
- The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion
- Study on Exploring the Effect of DPP-4 Inhibitors on β-cell Function by Using the Two-step Hyperglycemic Clamp
- The Role of Phosphodiesterase Inhibitors in Incretin Secretion
- Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP)
- Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy
- Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass Surgery
- Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial
- Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop
- Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes
- Sitagliptin and Brown Adipose Tissue
- Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI
- Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit
- Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
- Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
- Correlation Between Plasma- and Endothelial DPP-4 Activity
- Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
- The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
- DPP-4 Inhibition, Incretins and Islet Function
- Use of Sitagliptin to Decrease Microalbuminuria
- Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
- Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers
- Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
- Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery
- Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant
- Effect of Chronic Incretin-based Therapy in Cystic Fibrosis
- Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy
- Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
- Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users
- Glucose Variability With DPP-4 Inhibition
- Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant
- A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes
- ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia
- Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin
- Effect of DPP4 Inhibition on Growth Hormone Secretion
- Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"
- Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans
- Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation
- Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
- Sitagliptin Dose Determination Study
- Treatment of Diabetes After Gastric Bypass With Sitagliptin
- Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
- A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)
- Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)
- Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus
- A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 Diabetics
- Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus
- Pharmacogenetics of Ace Inhibitor-Associated Angioedema
- Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy
- Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes
- Changes in Bone Turnover With Increased Incretin Hormone Exposure
- An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)
- A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)
- Metformin and Sitagliptin in Women With Previous Gestational Diabetes
- Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes
- Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery
- JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients
- Effects of Sitagliptin (Januvia®) on Blood Glucose Control in Patients With Type 1 Diabetes
- Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea
- Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)
- Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)
- Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)
- Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes
- Treatment of Latent Autoimmune Diabetes of the Adult
- Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)
- A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
- The Role of P-glycoprotein in Sitagliptin Clinical Pharmacology
- A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy Subjects
- Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment
- Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment
- Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus
- Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV
- The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
- A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)
- Januvia Re-examination Study (MK-0431-181)
- A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)
- DPP-4 Inhibition and TZD for DM Prevention
- Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes
- A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
- Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
- Predictive Parameters for Efficacy of Sitagliptin and Metformin Combination
- Prevention of Cystic Fibrosis Diabetes
- A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)
- Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)
- Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation
- Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion
- Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus
- Sitagliptin Umbilical Cord Blood Transplant Study
- Effect of Sitagliptin on Graft Function Following Islet Transplantation
- Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism
- Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects
- MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)
- ALPHA Sitagliptin Add on to Metformin (0431-103)
- The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118)
- A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)
- Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM
- Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals
- Incretin Effect and Use After Clinical Islet Transplantation
- Sitagliptin in Renal Transplant Recipients
- Bone Turnover in Type 2 Diabetes Patients
- A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081)
- Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
- MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)
- Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome
- A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)
- Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress
- Effects of Glutamine on GLP-1 and Insulin Secretion in Man
- 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)
- The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects
- Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients With Heart Failure
- A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
- Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction
- Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)
- Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)
- Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
- Effects of Sitagliptin on Gastric Emptying in Healthy Subjects
- A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
- Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant
- Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus
- Beta-Cell Function and Sitagliptin Trial (BEST)
- Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes
- Incretins in Impaired Fasting Glucose
- Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)
- Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus
- MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)
- Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)
- Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)
- Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus
Clinical trials list
click for details